ArticleJournal of clinical medicine2025

Real-World, Single-Center Analysis of Cutaneous Adverse Events with Nemolizumab: Toward Safer and More Effective Use.

Akiko Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.